Update of minimally invasive surfactant therapy.

Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med (2008) 7.21

Early CPAP versus surfactant in extremely preterm infants. N Engl J Med (2010) 5.23

Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet (2011) 2.62

Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (2001) 2.04

Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics (1999) 2.01

European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update. Neonatology (2013) 1.96

Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol (2004) 1.62

Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed (2010) 1.61

Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics (2013) 1.58

Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics (2011) 1.57

Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr (2012) 1.54

Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr (2004) 1.53

Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2000) 1.52

Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology (2013) 1.50

Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics (2010) 1.47

Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ (2013) 1.44

Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med (1994) 1.42

Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (2012) 1.39

Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics (1972) 1.26

Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2012) 1.22

Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr (2015) 1.20

Respiratory support in preterm infants at birth. Pediatrics (2013) 1.18

Overview of surfactant replacement trials. J Perinatol (2005) 1.07

Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age </=27 weeks). Paediatr Anaesth (2007) 1.07

An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates. J Aerosol Med Pulm Drug Deliv (2010) 1.06

Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr (2000) 1.05

Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev (2009) 1.05

Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics (2013) 1.04

Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate (2005) 1.01

Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed (2012) 0.97

CPAP review. Eur J Pediatr (2011) 0.96

Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatr Pulmonol (1997) 0.96

Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Padiatr (2010) 0.95

Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol (2005) 0.92

Early surfactant in spontaneously breathing with nCPAP in ELBW infants--a single centre four year experience. Acta Paediatr (2008) 0.90

Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial. Am J Perinatol (2012) 0.89

[Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study]. Ugeskr Laeger (1992) 0.88

The laryngeal mask airway for administration of surfactant in two neonates with respiratory distress syndrome. Paediatr Anaesth (2004) 0.86

The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation. BMC Pediatr (2014) 0.86

Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways. J Matern Fetal Neonatal Med (2013) 0.85

Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies. Acta Paediatr (2014) 0.84

Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group. Br Med J (Clin Res Ed) (1987) 0.84

Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques. Neonatology (2012) 0.84

Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome. Cochrane Database Syst Rev (2011) 0.83

Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants. Acta Paediatr (2015) 0.82

Minimally invasive surfactant administration in preterm infants: a meta-narrative review. JAMA Pediatr (2014) 0.82

Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome. J Res Pharm Pract (2015) 0.82

Innovation in surfactant therapy II: surfactant administration by aerosolization. Neonatology (2012) 0.81

Nebulisation of surfactants in an animal model of neonatal respiratory distress. Arch Dis Child Fetal Neonatal Ed (1998) 0.80

Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery. J Perinatol (2015) 0.79

Surfactant administration without intubation in preterm infants with respiratory distress syndrome--our experiences. J Matern Fetal Neonatal Med (2014) 0.79

A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center. BMC Pediatr (2015) 0.78

European perspective on less invasive surfactant administration-a survey. Eur J Pediatr (2016) 0.77

A comparison of surfactant administration through i-gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams. Adv Biomed Res (2014) 0.77

Minimally Invasive Surfactant Therapy and Noninvasive Respiratory Support. Clin Perinatol (2016) 0.77

[Surfactant replacement therapy with a minimally invasive technique: Experience in a tertiary hospital]. An Pediatr (Barc) (2015) 0.76

Surfactant in spontaneous breathing with nCPAP: neurodevelopmental outcome at early school age of infants ≤ 27 weeks. Acta Paediatr (2010) 0.76

Observational Study on Less Invasive Surfactant Administration (LISA) in Preterm Infants<29 Weeks--Short and Long-term Outcomes. Z Geburtshilfe Neonatol (2015) 0.76

ProSeal LMA for surfactant administration. Paediatr Anaesth (2008) 0.76

Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study. Acta Biomed Ateneo Parmense (1997) 0.76

ProSealTM laryngeal mask airway for surfactant administration in the treatment of respiratory distress syndrome in a premature infant. Rev Bras Ter Intensiva (2012) 0.75